Ksolves India Limited (BOM:543599)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	104.84	73.13	85.73	68.95	80.89
Short-Term Investments	-	-	0.33	0.31	0.3	-
Cash & Short-Term Investments	104.84	104.84	73.45	86.04	69.25	80.89
Cash Growth	32.39%	42.73%	-14.63%	24.25%	-14.40%	14514.21%
Accounts Receivable	-	211.08	160.54	151.3	92.57	36.43
Other Receivables	-	-	0.07	0.27	1.36	1.09
Receivables	-	211.08	160.6	151.57	93.93	37.52
Prepaid Expenses	-	-	8.06	4.87	4.36	1.32
Other Current Assets	-	150.94	118.94	77.95	54.35	34.89
Total Current Assets	-	466.85	361.06	320.43	221.88	154.63
Property, Plant & Equipment	-	73.78	23.6	10.43	10.08	9.57
Long-Term Investments	-	-	-	-	-	0.28
Goodwill	-	0.6	0.6	0.6	0.6	0.6
Long-Term Deferred Tax Assets	-	9.66	5.41	5.04	2.59	0.96
Long-Term Deferred Charges	-	-	-	-	-	2.16
Other Long-Term Assets	-	12.95	4.9	4.38	1.7	3.95
Total Assets	-	563.84	395.57	340.88	236.85	172.14
Accounts Payable	-	3.82	2.51	4.67	5.68	1.04
Accrued Expenses	-	134.34	7.56	7.05	5.02	1.99
Short-Term Debt	-	90	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.78
Current Income Taxes Payable	-	-	116.65	83.51	50.64	31.05
Other Current Liabilities	-	47.48	10	8.23	2.04	0.83
Total Current Liabilities	-	275.64	136.72	103.46	63.38	35.69
Other Long-Term Liabilities	-	0	-0	0	-0	-
Total Liabilities	-	356.3	157.24	117.04	70.08	38.51
Common Stock	-	118.56	118.56	118.56	118.56	14.82
Additional Paid-In Capital	-	-	-	-	-	36.18
Retained Earnings	-	88.98	119.76	105.28	48.2	-
Comprehensive Income & Other	-	-	-	-	-	82.63
Shareholders' Equity	207.54	207.54	238.32	223.84	166.76	133.63
Total Liabilities & Equity	-	563.84	395.57	340.88	236.85	172.14
Total Debt	90	90	-	-	-	0.78
Net Cash (Debt)	14.84	14.84	73.45	86.04	69.25	80.12
Net Cash Growth	-81.26%	-79.80%	-14.63%	24.25%	-13.57%	-
Net Cash Per Share	0.63	0.63	3.10	3.63	2.92	3.38
Filing Date Shares Outstanding	23.71	23.72	23.71	23.71	23.71	23.71
Total Common Shares Outstanding	23.71	23.72	23.71	23.71	23.71	23.71
Working Capital	-	191.22	224.34	216.96	158.5	118.93
Book Value Per Share	8.75	8.75	10.05	9.44	7.03	5.64
Tangible Book Value	206.94	206.94	237.72	223.24	166.16	133.03
Tangible Book Value Per Share	8.72	8.72	10.03	9.41	7.01	5.61
Machinery	-	-	54.4	32.57	26.75	21.33

Updated Jan 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.